Hyrimoz 40 mg/0.8 ml
Hyrimoz 40 mg/0.8 ml is a medicine authorised by Swissmedic under authorisation number 67258. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 13 September 2019 and the authorisation is valid without a time limit. ATC code L04AB04 places the medicine in the group Immunosuppressants.
| Authorisation number | 67258 |
|---|---|
| Name | Hyrimoz 40 mg/0.8 ml |
| Full name | Hyrimoz 40 mg/0.8 ml, Injektionslösung in Fertigspritzen |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | L04AB04 |
| First authorisation | 13 September 2019 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Hyrimoz 40 mg/0.8 ml, Injektionslösung in Fertigspritzen | B | 13 September 2019 |
| 2 | Hyrimoz 20 mg/0.4 ml, Injektionslösung in Fertigspritzen | B | 16 October 2021 |
| 3 | Hyrimoz 80 mg/0.8 ml, Injektionslösung in Fertigspritzen | B | 28 May 2024 |
| 4 | Hyrimoz 40 mg/0.4 ml, Injektionslösung in Fertigspritzen | B | 28 May 2024 |
| 5 | Hyrimoz 20 mg/0.2 ml, Injektionslösung in Fertigspritzen | B | 28 May 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Fertigspritze(n) | L04AB04 | 07.15.0. | B |
| 2 | 2 | Fertigspritze(n) | L04AB04 | 07.15.0. | B |
| 3 | 6 | Fertigspritze(n) | L04AB04 | 07.15.0. | B |
| 4 | 2 | Fertigspritze(n) | L04AB04 | 07.15.0. | B |
| 5 | 1 | Fertigspritze(n) | L04AB04 | 07.15.0. | B |
| 6 | 2 | Fertigspritze(n) | L04AB04 | 07.15.0. | B |
| 7 | 1 | Fertigspritze(n) | L04AB04 | 07.15.0. | B |
| 8 | 2 | Fertigspritze(n) | L04AB04 | 07.15.0. | B |
| 9 | 6 | Fertigspritze(n) | L04AB04 | 07.15.0. | B |
| 10 | 2 | Fertigspritze(n) | L04AB04 | 07.15.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Hyrimoz 40 mg/0.8 ml authorised in Switzerland?
Yes. Hyrimoz 40 mg/0.8 ml is authorised by Swissmedic under authorisation number 67258, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Hyrimoz 40 mg/0.8 ml have?
Hyrimoz 40 mg/0.8 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Hyrimoz 40 mg/0.8 ml?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.